/neuro/taxonomy/term/217/all en /neuro/article/patients/your-monthly-update-neuro-patient-resource-centre As part of Parkinson's disease Awareness Month, we’re highlighting information resources on Parkinson's disease. Thu, 18 Apr 2024 20:06:46 +0000 Sabrina Burr 6005 at /neuro /neuro/article/research/neurodegenerative-gene-focus-new-open-science-project A new project led by scientists at The Neuro is zeroing in on a gene important to the study of neurological diseases. Fri, 15 Dec 2023 18:49:35 +0000 Neuro Communications 5871 at /neuro /neuro/article/neuroxxceptional-stories/anne-louise-lafontaine-neuroxxceptional-clinical-pioneer Dr. Anne Louise Lafontaine is Head of Neurology at the MUHC and Director of the Movement Disorders Clinic at The Neuro. Thu, 04 Apr 2019 20:41:47 +0000 Anita Kar 3492 at /neuro /neuro/article/temoignages-de-patients/paddling-past-parkinsons Patrick Sullivan keeps active and motivated in the face of disease Wed, 28 Apr 2021 20:45:14 +0000 Victor Swoboda 4979 at /neuro /neuro/article/major-funding-eye-tracking-app-diagnose-and-support-neurological-patients This mobile application will improve the quality of life and care of patients with neurological problems or neurodegenerative disorders. Tue, 02 Feb 2021 19:44:23 +0000 Anita Kar 4877 at /neuro /neuro/article/open-science-research/new-parkinsons-network-seeking-patients A new Parkinson’s network is inviting people living with the disease to help improve lives of patients and ultimately discover a cure. Mon, 22 Jun 2020 15:07:47 +0000 Communications staff 4641 at /neuro /neuro/channels/news/mni-scientist-receives-15m-grant-parkinsonsals-research-265527 <p><strong>CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research</strong></p> <p>CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.</p> Thu, 02 Feb 2017 17:09:22 +0000 shawn.hayward@mcgill.ca 2460 at /neuro /neuro/channels/news/using-sleep-disorder-predict-parkinsons-disease-295138 <p><strong>Large international study will help select and categorize patients for better clinical trials</strong></p> <p>A large multi-centre study of more than 1,200 patients provides important predictors of Parkinson’s disease progression, which will allow better candidate selection for clinical trials and more effective therapy development.</p> Mon, 04 Mar 2019 14:46:28 +0000 shawn.hayward@mcgill.ca 3402 at /neuro /neuro/channels/news/neuro-marks-parkinsons-awareness-month-286466 <p>April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.</p> Mon, 09 Apr 2018 17:59:06 +0000 shawn.hayward@mcgill.ca 3013 at /neuro /neuro/channels/news/april-parkinsons-disease-awareness-month-244818 <p>The Montreal Neurological Institute and Hospital - The Neuro, ƽÌØÎå²»ÖÐ and the ƽÌØÎå²»ÖÐ Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.</p> <p><strong>The Neuro to introduce experimental drug treatment </strong></p> Thu, 02 Apr 2015 13:43:31 +0000 anita.kar@mcgill.ca 1397 at /neuro /neuro/channels/news/parkinsons-month-2016 <h2>The Neuro – A Major Force in Parkinson’s Disease Research and Treatment</h2> Mon, 04 Apr 2016 20:00:13 +0000 shawn.hayward@mcgill.ca 1973 at /neuro /neuro/parkinsons-autoimmune-disease <p>A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at ƽÌØÎå²»ÖÐ have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.</p> <p>Using both cellular and mouse models, the team has shown that proteins produced by the two genes, known as PINK1 and Parkin, are required to prevent cells from being detected and attacked by the immune system.</p> Mon, 27 Jun 2016 14:04:13 +0000 shawn.hayward@mcgill.ca 2104 at /neuro /neuro/channels/news/health-science-leaders-join-forces-accelerate-development-treatments-neurological-diseases-267104 <p>Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.</p> Thu, 16 Mar 2017 16:21:40 +0000 shawn.hayward@mcgill.ca 2528 at /neuro /neuro/article/open-science-patients-research/opening-science-patients Ben Stecher thinks researchers have a moral obligation to share data Wed, 03 Jul 2019 14:52:31 +0000 Shawn Hayward 3878 at /neuro /neuro/article/open-science-research/4m-open-science-drug-screening Funds will support development of precision therapies for ALS and Parkinson’s disease Mon, 03 Jun 2019 19:39:22 +0000 Shawn Hayward 3845 at /neuro